Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome.

Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S.

Nat Commun. 2019 Sep 2;10(1):3931. doi: 10.1038/s41467-019-11947-7.

2.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.

Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.

Arthritis Rheumatol. 2019 Mar;71(3):451-459. doi: 10.1002/art.40727. Epub 2019 Jan 24.

PMID:
30225949
3.

Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.

Boutboul D, Kuehn HS, Van de Wyngaert Z, Niemela JE, Callebaut I, Stoddard J, Lenoir C, Barlogis V, Farnarier C, Vely F, Yoshida N, Kojima S, Kanegane H, Hoshino A, Hauck F, Lhermitte L, Asnafi V, Roehrs P, Chen S, Verbsky JW, Calvo KR, Husami A, Zhang K, Roberts J, Amrol D, Sleaseman J, Hsu AP, Holland SM, Marsh R, Fischer A, Fleisher TA, Picard C, Latour S, Rosenzweig SD.

J Clin Invest. 2018 Jul 2;128(7):3071-3087. doi: 10.1172/JCI98164. Epub 2018 Jun 11.

4.

Correction to: Use of Genetic Testing for Primary Immunodeficiency Patients.

Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Itan Y, Kobrynski L, Paris K, Torgerson TR, Verbsky JW, Wasserman RL, Hsieh EWY, Bleesing JJ, Chou JS, Lawrence MG, Marsh RA, Rosenzweig SD, Orange JS, Abraham RS.

J Clin Immunol. 2018 May;38(4):540-541. doi: 10.1007/s10875-018-0510-2.

PMID:
29781065
5.

Use of Genetic Testing for Primary Immunodeficiency Patients.

Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Tan Y, Kobrynski L, Paris K, Torgerson TR, Verbsky JW, Wasserman RL, Hsieh EWY, Blessing JJ, Chou JS, Lawrence MG, Marsh RA, Rosenzweig SD, Orange JS, Abraham RS.

J Clin Immunol. 2018 Apr;38(3):320-329. doi: 10.1007/s10875-018-0489-8. Epub 2018 Apr 19. Review. Erratum in: J Clin Immunol. 2018 May 21;:.

PMID:
29675737
6.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Schmidt KM, Mehta J, Wahezi DM, Ting TV, Verbsky JW, Eberhard BA, Spalding S, Chen C, Giannini EH.

Arthritis Rheumatol. 2018 Sep;70(9):1508-1518. doi: 10.1002/art.40509. Epub 2018 Jul 25.

7.

Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID).

Lawrence MG, Palacios-Kibler TV, Workman LJ, Schuyler AJ, Steinke JW, Payne SC, McGowan EC, Patrie J, Fuleihan RL, Sullivan KE, Lugar PL, Hernandez CL, Beakes DE, Verbsky JW, Platts-Mills TAE, Cunningham-Rundles C, Routes JM, Borish L.

J Clin Immunol. 2018 Apr;38(3):225-233. doi: 10.1007/s10875-018-0476-0. Epub 2018 Feb 17.

8.

A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay.

Thakar MS, Hintermeyer MK, Gries MG, Routes JM, Verbsky JW.

Front Immunol. 2017 Nov 8;8:1470. doi: 10.3389/fimmu.2017.01470. eCollection 2017. Review.

9.

The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency.

Bausch-Jurken MT, Verbsky JW, Gonzaga KA, Elms NP, Hintermeyer MK, Gauld SB, Routes JM.

J Clin Immunol. 2017 Jul;37(5):427-433. doi: 10.1007/s10875-017-0406-6. Epub 2017 Jun 7.

PMID:
28589420
10.

Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection.

Mitzelfelt KA, McDermott-Roe C, Grzybowski MN, Marquez M, Kuo CT, Riedel M, Lai S, Choi MJ, Kolander KD, Helbling D, Dimmock DP, Battle MA, Jou CJ, Tristani-Firouzi M, Verbsky JW, Benjamin IJ, Geurts AM.

Stem Cell Reports. 2017 Mar 14;8(3):491-499. doi: 10.1016/j.stemcr.2017.01.021. Epub 2017 Feb 24.

11.

Immunodeficiency Presenting as an Undiagnosed Disease.

Routes JM, Verbsky JW.

Pediatr Clin North Am. 2017 Feb;64(1):27-37. doi: 10.1016/j.pcl.2016.08.007. Review.

PMID:
27894450
12.

When to Suspect Autoinflammatory/Recurrent Fever Syndromes.

Verbsky JW.

Pediatr Clin North Am. 2017 Feb;64(1):111-125. doi: 10.1016/j.pcl.2016.08.008. Review.

PMID:
27894439
13.

Newborn screening for SCID: lessons learned.

Buelow BJ, Verbsky JW, Routes JM.

Expert Rev Hematol. 2016 Jun;9(6):579-84. doi: 10.1080/17474086.2016.1180243. Epub 2016 May 9. Review.

PMID:
27139719
14.

Intact Regulatory T-Cell Function but Defective Generation of IL-17A-Producing CD4+ T Cells in XIAP Deficiency.

Gurram B, Hammelev E, Syverson G, Haribhai D, Yan K, Simpson P, Salzman N, Verbsky JW.

J Pediatr Gastroenterol Nutr. 2016 Aug;63(2):218-25. doi: 10.1097/MPG.0000000000001122.

PMID:
26825770
15.

Practice parameter for the diagnosis and management of primary immunodeficiency.

Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, Keller M, Kobrynski LJ, Komarow HD, Mazer B, Nelson RP Jr, Orange JS, Routes JM, Shearer WT, Sorensen RU, Verbsky JW, Bernstein DI, Blessing-Moore J, Lang D, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller D, Spector SL, Tilles S, Wallace D; Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology.

J Allergy Clin Immunol. 2015 Nov;136(5):1186-205.e1-78. doi: 10.1016/j.jaci.2015.04.049. Epub 2015 Sep 12.

PMID:
26371839
16.

A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).

Yel L, Rabbat CJ, Cunningham-Rundles C, Orange JS, Torgerson TR, Verbsky JW, Wang Y, Fu M, Robins TS, Edwards MS, Nymann-Andersen J.

J Clin Immunol. 2015 Aug;35(6):573-82. doi: 10.1007/s10875-015-0184-y. Epub 2015 Aug 16.

17.

Newborn screening for SCID: where are we now?

Buelow BJ, Routes JM, Verbsky JW.

Expert Rev Clin Immunol. 2014 Dec;10(12):1649-57. doi: 10.1586/1744666X.2014.980816. Epub 2014 Nov 12. Review.

PMID:
25387596
18.

Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches.

Oberle EJ, Harris JG, Verbsky JW.

Clin Epidemiol. 2014 Oct 24;6:379-93. doi: 10.2147/CLEP.S53168. eCollection 2014. Review.

19.

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.

Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, Lyons JJ, Engelhardt KR, Zhang Y, Topcagic N, Roberson ED, Matthews H, Verbsky JW, Dasu T, Vargas-Hernandez A, Varghese N, McClain KL, Karam LB, Nahmod K, Makedonas G, Mace EM, Sorte HS, Perminow G, Rao VK, O'Connell MP, Price S, Su HC, Butrick M, McElwee J, Hughes JD, Willet J, Swan D, Xu Y, Santibanez-Koref M, Slowik V, Dinwiddie DL, Ciaccio CE, Saunders CJ, Septer S, Kingsmore SF, White AJ, Cant AJ, Hambleton S, Cooper MA.

Blood. 2015 Jan 22;125(4):591-9. doi: 10.1182/blood-2014-09-602763. Epub 2014 Oct 30.

20.

Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing Cholangitis.

Hartman HN, Niemela J, Hintermeyer MK, Garofalo M, Stoddard J, Verbsky JW, Rosenzweig SD, Routes JM.

J Clin Immunol. 2015 Jan;35(1):11-4. doi: 10.1007/s10875-014-0109-1. Epub 2014 Oct 29.

21.

Sarcoidosis and common variable immunodeficiency: similarities and differences.

Verbsky JW, Routes JM.

Semin Respir Crit Care Med. 2014 Jun;35(3):330-5. doi: 10.1055/s-0034-1376862. Epub 2014 Jul 9. Review.

PMID:
25007085
22.

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE, Zemel LS, Birmingham JD, Gottlieb BS, Miller ML, O'Neil K, Ruth NM, Wallace CA, Singer NG, Sandborg CI.

Arthritis Rheumatol. 2014 Sep;66(9):2570-9. doi: 10.1002/art.38699.

23.

Laboratory diagnosis of primary immunodeficiencies.

Locke BA, Dasu T, Verbsky JW.

Clin Rev Allergy Immunol. 2014 Apr;46(2):154-68. doi: 10.1007/s12016-014-8412-4. Review.

PMID:
24569953
24.

Early-onset stroke and vasculopathy associated with mutations in ADA2.

Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I.

N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.

25.

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.

Verbsky JW, Chatila TA.

Curr Opin Pediatr. 2013 Dec;25(6):708-14. doi: 10.1097/MOP.0000000000000029. Review.

26.

Screening for severe combined immunodeficiency in neonates.

Kelly BT, Tam JS, Verbsky JW, Routes JM.

Clin Epidemiol. 2013 Sep 16;5:363-9. doi: 10.2147/CLEP.S48890. eCollection 2013. Review.

27.

Heterogeneity and function of K(ATP) channels in canine hearts.

Zhang HX, Silva JR, Lin YW, Verbsky JW, Lee US, Kanter EM, Yamada KA, Schuessler RB, Nichols CG.

Heart Rhythm. 2013 Oct;10(10):1576-83. doi: 10.1016/j.hrthm.2013.07.020. Epub 2013 Jul 17.

28.

Update on the treatment of juvenile idiopathic arthritis.

Harris JG, Kessler EA, Verbsky JW.

Curr Allergy Asthma Rep. 2013 Aug;13(4):337-46. doi: 10.1007/s11882-013-0351-2. Review.

29.

Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.

Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, Noel RJ, Verbsky JW, Freeman AF, Janssen E, Bonilla FA, Pechacek J, Chandrasekaran P, Browne SK, Agharahimi A, Gharib AM, Mannurita SC, Yim JJ, Gambineri E, Torgerson T, Tran DQ, Milner JD, Holland SM.

J Allergy Clin Immunol. 2013 Jun;131(6):1611-23. doi: 10.1016/j.jaci.2012.11.054. Epub 2013 Mar 25.

30.

Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome.

Kessler EA, Vora SS, Verbsky JW.

Pediatr Rheumatol Online J. 2012 Aug 29;10(1):30. doi: 10.1186/1546-0096-10-30.

31.

Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).

Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, Singh S, Shahir KS, Tisol WB, Nugent ML, Rao RN, Mackinnon AC, Goodman LR, Simpson PM, Routes JM.

J Clin Immunol. 2013 Jan;33(1):30-9. doi: 10.1007/s10875-012-9755-3. Epub 2012 Aug 29.

32.

Monogenic causes of inflammatory disease in rheumatology.

Verbsky JW.

Curr Opin Rheumatol. 2012 Sep;24(5):506-14. doi: 10.1097/BOR.0b013e32835689b9. Review.

PMID:
22832824
33.

Requirements for growth and IL-10 expression of highly purified human T regulatory cells.

Bonacci B, Edwards B, Jia S, Williams CB, Hessner MJ, Gauld SB, Verbsky JW.

J Clin Immunol. 2012 Oct;32(5):1118-28. doi: 10.1007/s10875-012-9701-4. Epub 2012 May 5.

34.

Newborn screening for SCID: three years of experience.

Chase NM, Verbsky JW, Routes JM.

Ann N Y Acad Sci. 2011 Nov;1238:99-105. doi: 10.1111/j.1749-6632.2011.06241.x.

PMID:
22129057
35.

Granzyme B regulates antiviral CD8+ T cell responses.

Salti SM, Hammelev EM, Grewal JL, Reddy ST, Zemple SJ, Grossman WJ, Grayson MH, Verbsky JW.

J Immunol. 2011 Dec 15;187(12):6301-9. doi: 10.4049/jimmunol.1100891. Epub 2011 Nov 14.

36.

Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011).

Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, Reddy S, Margolis D, Casper J, Gries M, Desantes K, Hoffman GL, Brokopp CD, Seroogy CM, Routes JM.

J Clin Immunol. 2012 Feb;32(1):82-8. doi: 10.1007/s10875-011-9609-4. Epub 2011 Nov 10.

PMID:
22068910
37.

T-regulatory cells in primary immune deficiencies.

Verbsky JW, Chatila TA.

Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):539-44. doi: 10.1097/ACI.0b013e32834cb8fa. Review.

38.

Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.

Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, Serpe JM, Dasu T, Tschannen MR, Veith RL, Basehore MJ, Broeckel U, Tomita-Mitchell A, Arca MJ, Casper JT, Margolis DA, Bick DP, Hessner MJ, Routes JM, Verbsky JW, Jacob HJ, Dimmock DP.

Genet Med. 2011 Mar;13(3):255-62. doi: 10.1097/GIM.0b013e3182088158.

PMID:
21173700
39.

A timely arrival for genomic medicine.

Mayer AN, Dimmock DP, Arca MJ, Bick DP, Verbsky JW, Worthey EA, Jacob HJ, Margolis DA.

Genet Med. 2011 Mar;13(3):195-6. doi: 10.1097/GIM.0b013e3182095089. No abstract available.

PMID:
21169843
40.

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, McDonald D, Geha RS, Takada H, Krause JC, Creech CB, Ku CL, Ehl S, Maródi L, Al-Muhsen S, Al-Hajjar S, Al-Ghonaium A, Day-Good NK, Holland SM, Gallin JI, Chapel H, Speert DP, Rodriguez-Gallego C, Colino E, Garty BZ, Roifman C, Hara T, Yoshikawa H, Nonoyama S, Domachowske J, Issekutz AC, Tang M, Smart J, Zitnik SE, Hoarau C, Kumararatne DS, Thrasher AJ, Davies EG, Bethune C, Sirvent N, de Ricaud D, Camcioglu Y, Vasconcelos J, Guedes M, Vitor AB, Rodrigo C, Almazán F, Méndez M, Aróstegui JI, Alsina L, Fortuny C, Reichenbach J, Verbsky JW, Bossuyt X, Doffinger R, Abel L, Puel A, Casanova JL.

Medicine (Baltimore). 2010 Nov;89(6):403-25. doi: 10.1097/MD.0b013e3181fd8ec3.

41.

Newborn screening for T-cell deficiency.

Chase NM, Verbsky JW, Routes JM.

Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):521-5. doi: 10.1097/ACI.0b013e32833fd6fe. Review.

PMID:
20864885
42.

RSV infection--an immune balancing act: commentary on the article by Bem et al. on page 650.

Verbsky JW, Grossman WJ.

Pediatr Res. 2008 Jun;63(6):599-601. doi: 10.1203/PDR.0b013e318175d0ff. No abstract available.

PMID:
18520329
43.

Therapeutic use of T regulatory cells.

Verbsky JW.

Curr Opin Rheumatol. 2007 May;19(3):252-8. Review.

PMID:
17414951
44.

CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes.

Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW.

J Allergy Clin Immunol. 2007 Feb;119(2):482-7. Epub 2006 Dec 27.

PMID:
17196245
45.

Cellular and genetic basis of primary immune deficiencies.

Verbsky JW, Grossman WJ.

Pediatr Clin North Am. 2006 Aug;53(4):649-84. Review.

PMID:
16872998
46.
47.

T-cell stimulation and regulation: with complements from CD46.

Kemper C, Verbsky JW, Price JD, Atkinson JP.

Immunol Res. 2005;32(1-3):31-43. Review.

PMID:
16106057
48.

The pathway for the production of inositol hexakisphosphate in human cells.

Verbsky JW, Chang SC, Wilson MP, Mochizuki Y, Majerus PW.

J Biol Chem. 2005 Jan 21;280(3):1911-20. Epub 2004 Nov 5.

49.

Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ.

Immunity. 2004 Oct;21(4):589-601.

Supplemental Content

Loading ...
Support Center